1. Mpox and Chickenpox Coinfection: Case Series From Southern Nigeria.
- Author
-
Mmerem, Juliet I, Umenzekwe, Chukwudi C, Johnson, Simon M, Onukak, Asukwo E, Chika-Igwenyi, Nneka M, Chukwu, Sunday K, Onyeaghala, Chizaram A, Ozougwu, Jideofor J, Alasia, Datonye, Ehiakhamen, Odianosen, Nwankwo, Henry M, Ezejiofor, Ogochukwu I, Unigwe, Uche S, and Iroezindu, Michael O
- Subjects
- *
MONKEYPOX , *CHICKENPOX , *CHICKENPOX vaccines , *MIXED infections , *MONKEYPOX vaccines - Abstract
Background We describe clinicoepidemiologic characteristics of mpox-chickenpox coinfection in Nigeria. Methods A retrospective cohort analysis was performed of confirmed mpox cases in Nigeria from January 2022 to March 2023. Mpox and chickenpox were confirmed by real-time polymerase chain reaction (RT-PCR). Results Of 94 (60.0%) suspected cases, 56 had confirmed mpox, of whom 16 (28.6%) had chickenpox coinfection. The median age of confirmed mpox cases was 29 years (interquartile range, 20–37 years), 24 were men (60.7%), 6 (10.7%) were bisexual, and 5 (8.9%) died. Mpox-chickenpox–coinfected patients had more complications than mpox-monoinfected cases (56.3% vs 22.5%, P =.015). Conclusions The high frequency of mpox-chickenpox coinfection argues for accelerated access to mpox and chickenpox vaccines in Africa. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF